Source: Eur Respir Mon; 2009: 44: 57–70



Rating:

Share or cite this content

Citations should be made in the following way:
D.E. Midthun, J.R. Jett. Screening for lung cancer. Eur Respir Mon; 2009: 44: 57–70

Member's Comments

No comment yet.

Related content which might interest you: Screening Source: Eur Respir J 2003; 21: 3S-15S Year: 2003 What is the evidence so far: cytology and blood tests Source: Annual Congress 2005 - A sceptical look at lung cancer screening Year: 2005 Screening and diagnosis of lung cancer Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer Year: 2013 Early detection of lung cancer: role of biomarkers Source: Eur Respir J 2003; 21: 36S-44S Year: 2003 The diagnostic value of serum tumor markers in newly diagnosed lung cancer patients Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Evaluation of serum tumour markers in the lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 268s Year: 2002 Symptoms, signs and staging of lung cancer Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=86 Year: 2001 Interstitial lung diseases in a lung cancer screening trial Source: Eur Respir J 2011; 38: 392-400 Year: 2011 Scintigraphy with 99mTc-depreotide has a high sensitivity in detecting lung cancer Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques Year: 2007 Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC) Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Factors determining early adherence to a lung cancer screening protocol Source: Eur Respir J 2007; 30: 532-537 Year: 2007 Hyaluronan: A novel sputum marker for the screening and diagnosis of lung cancer patients Source: Annual Congress 2012 - Early detection of lung cancer Year: 2012 Prevalence and characterization of interstitial lung disease in a lung cancer screening program Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes Source: Eur Respir J 2010; 35: 146-151 Year: 2010 Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012 Risk factors and prognosis of non-solid nodules in a lung cancer screening program Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019 Screening for lung cancer Source: International Congress 2017 – Lung cancer for the pulmonologist Year: 2017 Lung cancer: immunopathology Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48 Year: 2001